As of the latest SEC filings, OCULAR THERAPEUTIX, INC (OCUL) is held by 186 institutional funds. The largest fund shareholder is Fidelity Growth Company Fund (FGCKX), holding an estimated $84,098,866.08 in market value, representing 0.10% of its portfolio.
Funds holding OCULAR THERAPEUTIX, INC (OCUL)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- OCUL
- CIK:
- 0001393434
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.10% | $84,098,866.08 | 9,407,032 | Feb 28, 2026 | Apr 24, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $55,479,363.94 | 6,550,102 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.05% | $38,961,737.43 | 4,599,969 | Mar 31, 2026 | May 28, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.10% | $23,561,656.08 | 2,635,532 | Feb 28, 2026 | Apr 24, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.11% | $22,633,576.80 | 2,531,720 | Feb 28, 2026 | Apr 24, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.05% | $17,428,921.49 | 1,860,077 | Apr 30, 2026 | Jun 26, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.02% | $16,512,307.35 | 1,949,505 | Mar 31, 2026 | May 28, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.11% | $12,967,917.27 | 1,531,041 | Mar 31, 2026 | May 28, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.10% | $12,493,250.00 | 1,475,000 | Mar 31, 2026 | May 28, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.11% | $12,194,818.02 | 1,439,766 | Mar 31, 2026 | May 28, 2026 |
|
FPHAX
Select Pharmaceuticals Portfolio
|
MF | Fidelity | 0.79% | $11,905,549.98 | 1,331,717 | Feb 28, 2026 | Apr 24, 2026 |
|
PJP
Invesco Pharmaceuticals ETF
|
ETF | Invesco | 3.07% | $10,229,144.67 | 1,091,691 | Apr 30, 2026 | Jun 26, 2026 |
|
QUAZX
AB Small Cap Growth Portfolio
|
MF | Independent / Boutique | 0.33% | $9,642,873.14 | 1,029,122 | Apr 30, 2026 | Jun 24, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.11% | $9,071,370.00 | 1,071,000 | Mar 31, 2026 | May 28, 2026 |
|
CHCLX
AB DISCOVERY GROWTH FUND, INC.
|
MF | Independent / Boutique | 0.31% | $8,299,974.11 | 885,803 | Apr 30, 2026 | Jun 24, 2026 |
|
VTWO
VANGUARD RUSSELL 2000 INDEX FUND
|
ETF | Vanguard | 0.05% | $8,240,471.82 | 921,753 | Feb 28, 2026 | Apr 28, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.02% | $7,972,879.74 | 891,821 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.04% | $7,363,305.84 | 823,636 | Feb 28, 2026 | Apr 24, 2026 |
|
FBIOX
Select Biotechnology Portfolio
|
MF | Fidelity | 0.13% | $7,008,960.00 | 784,000 | Feb 28, 2026 | Apr 24, 2026 |
|
FCTDX
Strategic Advisers Fidelity U.S. Total Stock Fund
|
MF | Fidelity | 0.00% | $6,588,333.00 | 736,950 | Feb 28, 2026 | Apr 24, 2026 |
|
FIDGX
Fidelity Small Cap Growth Fund
|
MF | Fidelity | 0.07% | $6,000,979.02 | 640,446 | Apr 30, 2026 | Jun 26, 2026 |
|
XPH
State Street(R) SPDR(R) S&P(R) Pharmaceuticals ETF
|
ETF | State Street (SPDR) | 1.71% | $5,263,452.81 | 621,423 | Mar 31, 2026 | May 28, 2026 |
|
DFAS
Dimensional U.S. Small Cap ETF
|
ETF | Dimensional Fund Advisors | 0.04% | $4,948,821.72 | 528,156 | Apr 30, 2026 | Jun 29, 2026 |
|
APDJX
Artisan International Small-Mid Fund
|
MF | Independent / Boutique | 0.18% | $4,740,447.25 | 559,675 | Mar 31, 2026 | May 29, 2026 |
|
FSPHX
Select Health Care Portfolio
|
MF | Fidelity | 0.07% | $4,421,142.90 | 494,535 | Feb 28, 2026 | Apr 24, 2026 |
Advertisement (320x50)